The summer of partnerships and discovery in Ohio’s bioscience communityPosted by BioOhio on Jul. 30, 2014
As we prepare for the Ohio Bioscience Expo & Showcase next week, bringing together bioscience companies and professionals from all over the state, we wanted to take a moment and recognize the impressive list of partnerships and collaborations in the news this summer. From device & drug development, patient care initiatives, commercialization efforts and research partnerships, it’s all coming together in Ohio.
The Neurotechnology Innovations Translator, with principal investigator Dr. Ali Rezai, backed by the Ohio Third Frontier and partners throughout Ohio industry and academia to the tune of $161M was announced in June.
The Ohio Clinical Trials Collaborative, part of Governor John Kasich’s Ohio Medical Corridor, held a public launch of the statewide IRB, connecting Ohio’s clinical resources, at the BIO International Convention in San Diego. OCTC seeks to establish Ohio as one of the most efficient and effective states in which to develop new therapeutics, diagnostics and medical devices.
The Austen BioInnovation Institute in Akron recently announced an agreement with ADB International Group to bring the E-QURE BST would healing device to the U.S. market. Navidea Biopharmaceuticals formed a joint venture named R-Nav with startup Rheumco to target rheumatologic and arthritic diseases. Backed by the National Science Foundation, UC San Francisco and University of Toledo formed the Center for Disruptive Musculoskeletal Innovations.
Akron Children’s Hospital, is leading research with 23 children’s hospitals around the country to improve the safety and care of patients during shift changes or hand-offs to new care providers. The University of Cincinnati, The Ohio State University and Indiana University formed the Midwest Consortium for Cancer Survivorship to enhance the quality of life for cancer survivors through patient-centered care beginning at the time of diagnosis.
The Wright State University and Premier Health Neuroscience Institute has added Dayton Children’s Hospital to its research program. The University of Cincinnati announced it is one of the founding members of the Midwest Pain Consortium, along with Eli Lilly and Co., which will work to develop next generation pain medications.
We’re excited to see so much activity around Ohio, connecting the amazing resources in our state. Great things happen when people work together.
We hope you can make it to the Expo next week, a free event designed to build even more exciting partnerships in Ohio’s bio community!
BioOhio BioBulletin, July 2014Posted by BioOhio on Jul. 18, 2014
Welcome to the July BioBulletin.
Trivia for this month: Charles Francis Brush, born and raised in Euclid, worked as an analytical and consulting chemist in Cleveland. His interest in electricity eventually led to his advancement of the electric arc light. Brush installed his first commercial arc lamp on the balcony of a doctor’s residence in Cincinnati. 12 arc lamps were later used to light the public square in Cleveland. This type of lighting changed life in American cities, making nighttime activities more popular and safe. Ohio-born pioneers continued to innovate light, including Thomas Edison from Milan, inventor of electric light, and Arthur Compton from Wooster and graduate from the College of Wooster, inventor of the florescent lighting tube.
Ohio Bioscience Expo & Showcase presented by BioOhio
An event focused on Ohio-based resources, business and innovation, August 5, 10am-5pm
Discover and connect with established & start-up bioscience companies, suppliers, service providers, and innovators. Meet companies who are moving bioscience technologies and products from concept to market, and the innovators who are on the idea-market path. Exhibitors and attendees alike will connect with new customers, find new collaborators and partners, meet colleagues in the industry, discover companies making cutting edge products and delivering quality services.
Educational workshops, hosted by event sponsors, will be held throughout the day, and a networking reception will take place from 4-5.
The event will be held in Aurora, located between Cleveland and Akron, at the Bertram Inn & Conference Center.
Workshop content to shine at the Ohio Bioscience Expo & ShowcasePosted by BioOhio on Jul. 16, 2014
The Ohio Bioscience Expo & Showcase is less than a month away! We have an amazing group of sponsors and exhibitors from around Ohio. The event is free to attend, and we still have space for new exhibitors!
Companies represent the fields of medical devices, pharmaceuticals, clinical research, contract manufacturing, agricultural biotechnology, product design, professional services, manufacturing services, workforce development, quality control, information technology, economic development, and more!
We are also delighted to present a series of exceptional (and free!) workshops to all Expo attendees. Workshops will run throughout the day alongside the exhibitor floor. Click here for the schedule and workshop details.
- University of Cincinnati ProPEL will discuss how to integrate internships into your business, finding value for both students and employers.
- MAGNET & BioEnterprise present Additive Manufacturing and its Impact on Medical Products, featuring experts in the industry.
- NanoLogix presents Dr. Sebastian Faro, who will discuss the N-Assay Multiwell Microplate Assay technology.
- McFlusion presents the science of clean-in-place (CIP) technology – TACCT (Time, Action, Coverage, Chemistry and Temperature) and the practical application of these critical cleaning parameters.
- Offenberger & White presents Brand Science 101 & Social Science 101, two sessions designed to improve your branding and social media presence.
- Taylor Strategy Partners presents a program to help participants understand the Millennial/Gen Y generation, relevant demographic trends, and the importance of assimilating them fully into the workforce.
The Ohio Bioscience Expo & Showcase will be held on August 5th, at the Bertram Inn & Conference Center, 10am – 5pm. See you there!
BioOhio BioBulletin, June 2014Posted by BioOhio on Jun. 25, 2014
Welcome to the June edition of the BioOhio BioBulletin.
Trivia: It seems well known that John Glenn (Cambridge); Jamie Farr (Toledo); Phil Donahue (Cleveland); and Dean Martin (Steubenville) are from Ohio, but did you know other Ohio natives include Clark Gable (Cadiz); Sara Jessica Parker (Nelsonville); Annie Oakley (Woodland/North Star); Ruby Dee and Paul Newman (Cleveland); Roy Rogers, Doris Day, Ted Turner, and Steven Spielberg (Cincinnati); and Nancy Wilson (Chillicothe)? Next month we will talk famous Ohio science inventions.
August 5 – Ohio Bioscience Expo & Showcase
Calling all Exhibitors! This event will be MD&M + BIO + AdvaMed + Pittcon + RS&A + MEDICA + HIMMS + ACRP + ASCO+++, all rolled into one. If you’re an established or start-up bioscience company, supplier, service provider, or innovator, you need to exhibit at this event. Exhibitors and attendees alike will connect with new customers, find new collaborators and partners, meet colleagues in the industry, and discover companies making cutting edge products and delivering quality services. We have a super location in Aurora, located between Cleveland and Akron, at the stunning Bertram Inn & Conference Center. Book your exhibitor space now, and sponsorship opportunities are available.
BioOhio’s Annual Conference is back on the road this year, and back to the roots, focusing on our members, innovation and growth in Ohio’s bioscience community. Registration is open and sponsorship opportunities are available.
Southern Ohio, September 18 at Cooper Creek Event Center
Northern Ohio, October 16 at Bertram Inn & Conference Center
Central Ohio, November 12 at Pinnacle Golf Club
Check our calendar often for industry/member functions, like these…
- July 24 - Cyber Security Risks for Medical Device Manufacturers presented by Oswald Companies
- August 17-20 - Cancer Stem Cell Conference presented by CWRU National Center for Regenerative Medicine
- September 11 - Trade Secrets and Non-compete Agreements presented by McNees Wallace & Nurick
- September 12-13 - Cleveland HeartLab 5th Annual Symposium (BioOhio members save $50 on registration)
- September 22 - OSU Department of Chemical and Biomolecular Engineering 3rd Annual Graduate Research Symposium
- October 6-8 - AdvaMed 2014 (BioOhio members save 20% on registration)
A lot is happening around Ohio in the bioscience industry! Here’s a sample of the news we posted this month on our news page. Share your news with us and we’ll help spread the word. Be sure to bookmark bioohio.com/blog for daily updates.
- ClinicalRM and the Ohio Clinical Trials Collaborative launch partnership offering joint services for new biologics, drugs and medical devices.
- Cincinnati Children’s Hospital Medical Center partners with Alexion to launch a rare disease fund, also raises $2M for cystic fibrosis & pulmonary programs.
- Ohio’s Straight A Fund recently awarded $150M in education grants around Ohio for STEM education and related projects.
- Bacterial Robotics is working with Nationwide Children’s Hospital to fight cancer.
- The Neurotechnology Innovations Translator is launched with $161M public/private investment, Dr. Ali Rezai to be principal investigator.
- Assurex Health promotes Gina Drosos to President and CEO and lands a big contract with the VA.
- Cardinal Health creates workspace to foster collaboration and idea sharing while also being named 9th Greenest Company in the U.S. by Newsweek.
- OsteoSymbionics announces 510(k), Valtronic adds new equipment, Ganeden gains global footprint, Alkermes initiates efficacy studies, Cleveland Clinic partners with Parker Hannifin, ABIA partners with OMNOVA, and OSU teams up with Michigan!
For more info about other BioOhio initiatives like…
- talent & training, click here
- member discounts and savings, click here
- wellness, heart health promotion with Cleveland HeartLab, click here
- advocacy and public policy efforts, click here
I look forward to your participation and attendance at our events. Please feel welcome to contact me anytime with questions or if you need assistance.
Engage, Bring It!
John F. Lewis, Jr.
BioOhio, President & CEO
(614) 675-3686 x1262
PhRMA releases new report: Medicines in Development for Older AmericansPosted by BioOhio on Jun. 17, 2014
The report is free and available to download from long time BioOhio member and supporting partner, PhRMA, the Pharmaceutical Research and Manufacturers of America.
In addition to information on some of the medicines in the pipeline, the new report delves into treatment advances for healthier aging, the Medicare prescription drug program’s role in improved health outcomes and cost savings, the importance of adherence to medicines to the health of patients and the economy, and comprehensive facts about chronic diseases in the United States. The following is a brief summary:
America’s biopharmaceutical research companies currently are developing 435 innovative new medicines to target 15 leading chronic conditions affecting the Medicare population. These medicines in development – all either in clinical trials or under review by the Food and Drug Administration (FDA) – include 110 for diabetes, 62 for rheumatoid arthritis and osteoarthritis, 67 for Alzheimer’s disease, 61 for heart disease and 40 for chronic obstructive pulmonary disease (COPD).
With the aging population and life expectancy climbing, higher rates of chronic diseases remain a major challenge for our health care system. Tremendous advances in medical science, combined with the benefits of lifestyle changes, have allowed more individuals to continue living their lives with one or more chronic illnesses. Today nearly 92 percent of older adults have at least one chronic condition, and 77 percent have at least two, according to the National Council on Aging (NCOA).
“Treatment advances have led to significant progress against many chronic diseases, but challenges remain,” said PhRMA President and CEO John J. Castellani. “The 435 medicines in the pipeline today offer incredible hope for aging patients and the sustainability of our health care system.”